In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y
- PMID: 34606305
- DOI: 10.7326/ACPJ202110190-115
In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y
Abstract
Menzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384:1800-9. 33979488.
Comment on
-
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.N Engl J Med. 2021 May 13;384(19):1800-1809. doi: 10.1056/NEJMoa2034975. N Engl J Med. 2021. PMID: 33979488 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical